Category Added in a WPeMatico Campaign
Twenty20 Energy-Built Plant Will Provide 45MW of Power to Port Moresby Area SINGAPORE--(BUSINESS WIRE)--Twenty20 Energy announced today that the Dirio...
INDIANAPOLIS, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Kite Realty Group Trust (NYSE: KRG), a premier owner and operator of high-quality,...
3 Year Contract Delivers Data Governance and Entity Extraction with Machine Learning Capabilities – Reducing Risk Profile RESEARCH TRIANGLE PARK,...
On 11 February 2022, AS Tallink Grupp and AS Tallinna Sadam concluded a settlement upon approval of which by the...
On 11 February 2022, AS Tallink Grupp and AS Tallinna Sadam concluded a settlement upon approval of which by the...
Business Highlights Record total full year 2021 revenues of $111.1 million, up 26% year over year Analytics revenue accounted for...
WALL, N.J., Feb. 15, 2022 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer...
Fourth quarter revenue of $67.3 million, up 58% YoY; GAAP operating income of $5.6 million; Adjusted EBITDA of $10.6 million;...
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- Currency Exchange International, Corp. (the “Company”) (TSX: CXI; OTCBB: CURN), today reported net...
Aktia Bank PlcStock Exchange Release16 February 2022 at 8.00 a.m. Aktia Bank Plc’s Financial Statement Release January–December 2021: 2021 –...
Management Board of Northern Horizon Capital AS (the Management Company) has approved the unaudited consolidated interim financial statements of Baltic...
Management Board of Northern Horizon Capital AS (the Management Company) has approved the unaudited consolidated interim financial statements of Baltic...
Company to host conference call and webcast on March 24, 2022 at 12:30 p.m. GMT / 8:30 a.m. ET OXFORD,...
Earnings Call Webcast to Discuss 2021 Fourth Quarter and Full Year Financial Results and COVID-19 Updates Scheduled to Post to...
SUWON, South Korea--(BUSINESS WIRE)--#7thOPTCongress--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced that Behfar Ardehali, Ph.D., Senior...
